# Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors

> **NCT05378256** · NA · COMPLETED · sponsor: **Centre Hospitalier Régional d'Orléans** · enrollment: 40 (actual)

## Conditions studied

- Lymphoma
- Peripheral Neuropathy

## Interventions

- **OTHER:** Clinical scales of CIPN

## Key facts

- **NCT ID:** NCT05378256
- **Lead sponsor:** Centre Hospitalier Régional d'Orléans
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-10
- **Primary completion:** 2025-03-11
- **Final completion:** 2025-03-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05378256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05378256, "Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05378256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*